BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 19215705)

  • 1. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P; Jackson R; Cooper K; Rees A; Simpson E; Read R; Nicholson K
    Health Technol Assess; 2009 Feb; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
    Jackson RJ; Cooper KL; Tappenden P; Rees A; Simpson EL; Read RC; Nicholson KG
    J Infect; 2011 Jan; 62(1):14-25. PubMed ID: 20950645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitors for preventing and treating influenza in adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Onakpoya I; Mahtani KR; Nunan D; Howick J; Heneghan CJ
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD008965. PubMed ID: 24718923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
    Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K
    Health Technol Assess; 2003; 7(35):iii-iv, xi-xiii, 1-170. PubMed ID: 14609480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
    Burch J; Paulden M; Conti S; Stock C; Corbett M; Welton NJ; Ades AE; Sutton A; Cooper N; Elliot AJ; Nicholson K; Duffy S; McKenna C; Stewart L; Westwood M; Palmer S
    Health Technol Assess; 2009 Nov; 13(58):1-265, iii-iv. PubMed ID: 19954682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB; Bellantonio S; Rose DN
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):321-9. PubMed ID: 12965940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
    Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
    BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
    Risebrough NA; Bowles SK; Simor AE; McGeer A; Oh PI
    J Am Geriatr Soc; 2005 Mar; 53(3):444-51. PubMed ID: 15743287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
    Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T
    Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of newer treatment strategies for influenza.
    Smith KJ; Roberts MS
    Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and early treatment of influenza in healthy adults.
    Demicheli V; Jefferson T; Rivetti D; Deeks J
    Vaccine; 2000 Jan; 18(11-12):957-1030. PubMed ID: 10590322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.